Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Alglucosidase alfa 2件: Alglucosidase alfa; Alpha-glucosidase1件: Alglucosidase alfa (Lumizyme, LUMIZYME) 💬 1件: GAA 💬 3件: Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 256 💬
2 Lumacaftor
(Lumacaftor)		1件: Lumacaftor1件: Lumacaftor (Lumacaftor) 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3 Lumasiran
(Lumasiran sodium)		1件: Lumasiran2件: Lumasiran (Lumasiran),
Lumasiran sodium (Lumasiran sodium) 💬 		1件: HAO 💬 2件: Glyoxylate and dicarboxylate metabolism, Peroxisome 💬1件: 234 💬
4 Lumiracoxib
(Lumiracoxibum)		1件: Lumiracoxib1件: Lumiracoxib (Lumiracoxib) 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
5 Sodium oxybate 1件: Sodium oxybate1件: Sodium oxybate (LUMRYZ) 💬 --2件: 6, 149 💬
6 Sulfur hexafluoride 2件: Sulfur hexafluoride; Sulphur hexafluoride1件: Sulfur hexafluoride (Lumason, LUMASON) 💬 --3件: 96, 97, 215 💬